Concepedia

Elisabeth Bechter

EB

Statistics

Publications

5

Citations

262

H-Index

5

Active since

1999

Affiliations

Novartis (Switzerland)(Current)

Elisabeth Bechter is an author at Novartis (Switzerland) specializing in molecular biology, molecular oncology, and life sciences.

Publications per year

1999–2024

5

Publications

5

Discovery of WRN inhibitor HRO761 with synthetic lethality in MSI cancers

Stéphane Ferretti, Jacques Hamon, Ruben de Kanter et al. · Nature · 2024 · 113 citations · Full text

, , +17

PAX8 and MECOM are interaction partners driving ovarian cancer

Melusine Bleu, Fanny Mermet‐Meillon, Verena Apfel et al. · Nature Communications · 2021 · 82 citations · Full text

, , +17

P53 mutants without a functional tetramerisation domain are not oncogenic 1 1Edited by A. R. Fersht

Patrick Chêne, Elisabeth Bechter · Journal of Molecular Biology · 1999 · 26 citations

, , +14

Challenges for the Discovery of Non‐Covalent WRN Helicase Inhibitors

Alisa Heuser, Wassim Abdul Rahman, Elisabeth Bechter et al. · ChemMedChem · 2024 · 24 citations

, , +15

Cellular characterisation of p53 mutants with a single missense mutation in the β-strand 326–333 and correlation of their cellular activities with in vitro properties

Patrick Chêne, Elisabeth Bechter · Journal of Molecular Biology · 1999 · 17 citations

, , +12

1–5 of 5